LianBio
LIANY · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $347 | $300 | $297 | $323 |
| Gross Profit | -$347 | -$300 | -$297 | -$323 |
| % Margin | – | – | – | – |
| R&D Expenses | $6,086 | $9,019 | $9,353 | $10,810 |
| G&A Expenses | $0 | $17,283 | $15,590 | $15,138 |
| SG&A Expenses | $16,037 | $17,283 | $15,126 | $15,138 |
| Sales & Mktg Exp. | $0 | $0 | -$464 | $0 |
| Other Operating Expenses | -$1 | $141 | $869 | $0 |
| Operating Expenses | $22,122 | $26,003 | $24,479 | $25,595 |
| Operating Income | -$22,469 | -$26,301 | -$25,044 | -$25,969 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $405,423 | $2,848 | $3,623 | $2,362 |
| Pre-Tax Income | $382,954 | -$23,453 | -$21,421 | -$23,607 |
| Tax Expense | -$779 | $586 | $200 | $437 |
| Net Income | $383,733 | -$24,039 | -$21,621 | -$24,045 |
| % Margin | – | – | – | – |
| EPS | 3.56 | -0.22 | -0.2 | -0.22 |
| % Growth | 1,718.2% | -10% | 9.1% | – |
| EPS Diluted | 3.55 | -0.22 | -0.2 | -0.22 |
| Weighted Avg Shares Out | 107,781 | 107,168 | 107,164 | 107,162 |
| Weighted Avg Shares Out Dil | 108,125 | 107,168 | 107,164 | 107,162 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,178 | $2,707 | $2,754 | $2,406 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $347 | $300 | $297 | $323 |
| EBITDA | $383,301 | -$23,154 | -$24,710 | -$23,238 |
| % Margin | – | – | – | – |